QQQ ()
DIA ()
SPY ()
TLT ()
GLD ()
$ na
-- x --
-- x --
-- - --
-- - --
--
na
--
--
--
TBD
--
-- (--)
--
TBD --
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
No Data found
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 hc-wainwright--co-reiterates-buy-on-puma-biotechnology-maintains-7-price-target

HC Wainwright & Co. analyst Edward White reiterates Puma Biotechnology (NASDAQ:PBYI) with a Buy and maintains $7 price t...

 puma-biotechnology-sees-q3-revenue-50m-53m-vs-5785m-est-fy24-revenue-183m-190m-vs-21763m-est

Third Quarter and Full Year 2024 Financial Outlook Third Quarter 2024Full Year 2024Net Product Revenue$50 -53 million$183 - $19...

 puma-biotechnology-q2-2024-adj-eps-005-beats-013-estimate-sales-47100m-beat-44700m-estimate

Puma Biotechnology (NASDAQ:PBYI) reported quarterly losses of $(0.05) per share which beat the analyst consensus estimate of $(...

 hc-wainwright--co-reiterates-buy-on-puma-biotechnology-maintains-7-price-target

HC Wainwright & Co. analyst Edward White reiterates Puma Biotechnology (NASDAQ:PBYI) with a Buy and maintains $7 price t...

 hc-wainwright--co-reiterates-buy-on-puma-biotechnology-maintains-7-price-target

HC Wainwright & Co. analyst Edward White reiterates Puma Biotechnology (NASDAQ:PBYI) with a Buy and maintains $7 price t...

 hc-wainwright--co-reiterates-buy-on-puma-biotechnology-maintains-7-price-target

HC Wainwright & Co. analyst Edward White reiterates Puma Biotechnology (NASDAQ:PBYI) with a Buy and maintains $7 price t...

 puma-biotechnology-announced-presentation-of-findings-from-phase-ii-study-of-alisertib-in-endocrine-resistant-metastatic-breast-cancer-asco-2024

Puma Biotechnology, Inc. (NASDAQ:PBYI), a biopharmaceutical company, announced the presentation of biomarker findings from a Ph...

 puma-biotechnology-to-join-russell-3000-index

Puma Biotechnology, Inc. (NASDAQ:PBYI), a biopharmaceutical company, is set to join the broad-market Russell 3000® Index at the...

 pfizer-wins-1075m-verdict-against-astrazeneca-over-cancer-drug-patent-dispute

A Delaware jury ordered AstraZeneca to pay Pfizer $107.5 million, ruling that AstraZeneca's lung cancer drug Tagrisso infri...

 hc-wainwright--co-reiterates-buy-on-puma-biotechnology-maintains-7-price-target

HC Wainwright & Co. analyst Edward White reiterates Puma Biotechnology (NASDAQ:PBYI) with a Buy and maintains $7 price t...

Core News & Articles

- Reuters

 hc-wainwright--co-reiterates-buy-on-puma-biotechnology-maintains-7-price-target

HC Wainwright & Co. analyst Edward White reiterates Puma Biotechnology (NASDAQ:PBYI) with a Buy and maintains $7 price t...

 puma-biotechnology-sees-q2-net-product-revenue-43m-45m-fy24-net-product-revenue-183m-190m

Second Quarter and Full Year 2024 Financial Outlook Second Quarter 2024Full Year 2024Net Product Revenue$43 -45 million$183 - $...

 puma-biotechnology-q1-2024-adj-eps-005-beats-022-estimate-sales-43800m-beat-41050m-estimate

Puma Biotechnology (NASDAQ:PBYI) reported quarterly losses of $(0.05) per share which beat the analyst consensus estimate of $(...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION